Publications

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Development and validation of an LC-MS/MS method for the quantification of the KRAS^G12C inhibitor divarasib.

01-10-2026

European journal of cancer (Oxford, England : 1990)

International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.

09-09-2026

Seminars in cancer biology

Beyond the traditional dish: Advanced 3D ex vivo culture platforms for tumor modelling.

01-09-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Response prediction after neoadjuvant chemoradiotherapy in esophageal cancer using FDG-PET and multiparametric MRI: A prospective multicenter study.

01-09-2026

Prostate cancer and prostatic diseases

Reducing adverse effects in hypofractionated radiotherapy for prostate cancer: Clinical evidence and emerging mitigation strategies.

01-09-2026

Health policy (Amsterdam, Netherlands)

Coverage with evidence development programs: a scoping review on characteristics and patient access.

01-09-2026

Clinical and translational radiation oncology

Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial.

01-09-2026

Clinical pharmacokinetics

Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation.

01-09-2026

European urology focus

Oncological Outcomes of Robot-assisted PSMA-guided Salvage Surgery in Recurrent Prostate Cancer: Insights from the Prospective TRACE-I Trial.

29-08-2026

Lancet (London, England)

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

29-08-2026

European journal of cancer (Oxford, England : 1990)

Trametinib for NRAS-mutated tumors: Results from the Drug Rediscovery Protocol.

26-08-2026

ACS chemical biology

Molecular Glue and Phosphorylation-Dependent 14-3-3 Recruitment to p53 with an Engineered Interaction Cassette.

21-08-2026

Nature aging

Turning CDK4/6 inhibitors against the dark side of senescence.

20-08-2026

Molecular systems biology

Systematic comparison of estimates of transcription factor activity by ATAC-seq and multiplexed reporter assays.

17-08-2026

Seminars in immunology

The multifaceted roles of cellular senescence in liver pathophysiology: from tissue repair to tumor progression.

17-08-2026

Nature communications

A ubiquitin chain-feeding mechanism for BRCA1-A.

11-08-2026

Nucleic acids research

Nuclear receptor Nur77 resolves the inflammatory response of macrophages primarily by regulating expression of AP-1 transcription factors and their target genes.

10-08-2026

International journal of computer assisted radiology and surgery

Precise and minimally invasive localization of pelvic nodes during robot-assisted surgery using image-guided navigation.

07-08-2026

Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy

A proof-of-concept study of optical tissue sensing during vacuum-assisted breast biopsy procedures.

06-08-2026

Breast cancer research and treatment

Invasive lobular breast cancer in young patients without adjuvant systemic treatment: 15-year survival outcomes.

06-08-2026

Clinical cancer research : an official journal of the American Association for Cancer Research

Transcriptomic Insights into Lobular Breast Cancer Biology and Patient Outcomes: Analysis of the MINDACT Clinical Trial.

03-08-2026

JAMA network open

Surgical Management of Early-Onset Breast Cancer Among Young BRCA1 and BRCA2 Carriers.

03-08-2026

Cancer chemotherapy and pharmacology

Dosing challenges for chemotherapy and immunotherapy in congenital achondroplasia: a case report and literature review.

03-08-2026

The EMBO journal

Alterations in chromatin organization promote totipotent-like features in a DPPA2/DUX-dependent manner.

01-08-2026

Breast (Edinburgh, Scotland)

Towards patient-centered research in pregnancy-associated breast cancer: creating a science agenda through a priority-setting-partnership.

01-08-2026

Annals of surgical oncology

ASO Author Reflections: Beyond Time to Diagnosis: The Lasting Impact of Diagnostic Experience in GIST.

01-08-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Automated prospective quality assurance of tumor segmentation and treatment planning in the hypo-FLAME 3.0 trial.

01-08-2026

Nature

TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer.

01-08-2026

The Lancet. Oncology

Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysis.

01-08-2026

Neuro-oncology practice

Symptom burden in young adult brain tumor survivors: Key intervention targets based on patient-reported outcome network analyses.

01-08-2026

Journal of cancer survivorship : research and practice

Can't I continue to exercise here? Exploring experiences, barriers, and facilitators for physical therapists and survivors of cancer to promote exercise maintenance.

01-08-2026

Nature genetics

The PRECISE European initiative for cancer-vulnerability mapping and prediction.

01-08-2026

Annals of oncology : official journal of the European Society for Medical Oncology

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

01-08-2026

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Prestin as a potential biomarker for cochlear injury: Current evidence and future directions.

01-08-2026

Surgical endoscopy

Real-time surgical navigation for intraoperative lymph node localization during targeted robot-assisted pelvic and retroperitoneal lymph node dissection.

01-08-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Dose-based evaluation of delineation variation in radiotherapy: A scoping review.

01-08-2026

Trends in immunology

Exploiting immunogenic cell death to promote antitumor immunity.

01-08-2026

Tumori

Optimising combination therapy for paediatric, adolescent and young adult patients with non-rhabdomyosarcoma soft tissue sarcomas: The OCTOPUS platform trial.

30-07-2026

The FEBS journal

Inhibition of mitochondrial protein translation sensitizes tumor cells to death receptor 5 agonistic antibody.

29-07-2026

Cell reports

GRHL and PGR control WNT4 expression via 3D looping of conserved and species-specific enhancers.

28-07-2026

Acta oncologica (Stockholm, Sweden)

The impact of pazopanib and extremity radiotherapy on transaminase elevations in soft tissue sarcoma.

28-07-2026

Journal of occupational rehabilitation

Health- and Work-Related Outcomes in Partners of Cancer Survivors: A Prospective Cohort Study.

21-07-2026

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

20-07-2026

Journal of occupational rehabilitation

SusTained Employability in cancer Patients and their partnerS: Results of a Randomized Controlled Trial into the Effectiveness of the STEPS Program.

20-07-2026

Journal of occupational rehabilitation

Cost-Effectiveness of the STEPS Work Participation Program Compared to Usual Care, for Cancer Survivors: An Economic Evaluation Alongside a Randomized Controlled Trial.

20-07-2026

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Brief Report: Reducing Lorlatinib-Related Adverse Events by Establishing the Optimal Exposure-Toxicity Threshold in Patients With NSCLC.

16-07-2026

Cancer research

Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production.

15-07-2026

Clinical cancer research : an official journal of the American Association for Cancer Research

The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacy.

13-07-2026

European journal of nuclear medicine and molecular imaging

Real-world use of PSMA imaging in metastatic castration-sensitive prostate cancer: Findings from the CAPRI-3 registry.

10-07-2026

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Self-reported peripheral neuropathic symptoms in long-term adolescent and young adult (AYA) cancer survivors: results of the SURVAYA study.

02-07-2026

Development and validation of an LC-MS/MS method for the quantification of the KRASG12C inhibitor divarasib.

International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.

Beyond the traditional dish: Advanced 3D ex vivo culture platforms for tumor modelling.

Response prediction after neoadjuvant chemoradiotherapy in esophageal cancer using FDG-PET and multiparametric MRI: A prospective multicenter study.

Reducing adverse effects in hypofractionated radiotherapy for prostate cancer: Clinical evidence and emerging mitigation strategies.

Coverage with evidence development programs: a scoping review on characteristics and patient access.

Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial.

Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation.

Oncological Outcomes of Robot-assisted PSMA-guided Salvage Surgery in Recurrent Prostate Cancer: Insights from the Prospective TRACE-I Trial.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Trametinib for NRAS-mutated tumors: Results from the Drug Rediscovery Protocol.

Molecular Glue and Phosphorylation-Dependent 14-3-3 Recruitment to p53 with an Engineered Interaction Cassette.

Turning CDK4/6 inhibitors against the dark side of senescence.

Systematic comparison of estimates of transcription factor activity by ATAC-seq and multiplexed reporter assays.

The multifaceted roles of cellular senescence in liver pathophysiology: from tissue repair to tumor progression.

A ubiquitin chain-feeding mechanism for BRCA1-A.

Nuclear receptor Nur77 resolves the inflammatory response of macrophages primarily by regulating expression of AP-1 transcription factors and their target genes.

Precise and minimally invasive localization of pelvic nodes during robot-assisted surgery using image-guided navigation.

A proof-of-concept study of optical tissue sensing during vacuum-assisted breast biopsy procedures.

Invasive lobular breast cancer in young patients without adjuvant systemic treatment: 15-year survival outcomes.

Transcriptomic Insights into Lobular Breast Cancer Biology and Patient Outcomes: Analysis of the MINDACT Clinical Trial.

Surgical Management of Early-Onset Breast Cancer Among Young BRCA1 and BRCA2 Carriers.

Dosing challenges for chemotherapy and immunotherapy in congenital achondroplasia: a case report and literature review.

Alterations in chromatin organization promote totipotent-like features in a DPPA2/DUX-dependent manner.

Towards patient-centered research in pregnancy-associated breast cancer: creating a science agenda through a priority-setting-partnership.

ASO Author Reflections: Beyond Time to Diagnosis: The Lasting Impact of Diagnostic Experience in GIST.

Automated prospective quality assurance of tumor segmentation and treatment planning in the hypo-FLAME 3.0 trial.

TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer.

Symptom burden in young adult brain tumor survivors: Key intervention targets based on patient-reported outcome network analyses.

Can't I continue to exercise here? Exploring experiences, barriers, and facilitators for physical therapists and survivors of cancer to promote exercise maintenance.

The PRECISE European initiative for cancer-vulnerability mapping and prediction.

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Prestin as a potential biomarker for cochlear injury: Current evidence and future directions.

Real-time surgical navigation for intraoperative lymph node localization during targeted robot-assisted pelvic and retroperitoneal lymph node dissection.

Dose-based evaluation of delineation variation in radiotherapy: A scoping review.

Exploiting immunogenic cell death to promote antitumor immunity.

Optimising combination therapy for paediatric, adolescent and young adult patients with non-rhabdomyosarcoma soft tissue sarcomas: The OCTOPUS platform trial.

Inhibition of mitochondrial protein translation sensitizes tumor cells to death receptor 5 agonistic antibody.

GRHL and PGR control WNT4 expression via 3D looping of conserved and species-specific enhancers.

The impact of pazopanib and extremity radiotherapy on transaminase elevations in soft tissue sarcoma.

Health- and Work-Related Outcomes in Partners of Cancer Survivors: A Prospective Cohort Study.

Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

SusTained Employability in cancer Patients and their partnerS: Results of a Randomized Controlled Trial into the Effectiveness of the STEPS Program.

Cost-Effectiveness of the STEPS Work Participation Program Compared to Usual Care, for Cancer Survivors: An Economic Evaluation Alongside a Randomized Controlled Trial.

Brief Report: Reducing Lorlatinib-Related Adverse Events by Establishing the Optimal Exposure-Toxicity Threshold in Patients With NSCLC.

Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production.

The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacy.

Real-world use of PSMA imaging in metastatic castration-sensitive prostate cancer: Findings from the CAPRI-3 registry.

Self-reported peripheral neuropathic symptoms in long-term adolescent and young adult (AYA) cancer survivors: results of the SURVAYA study.

This site uses cookies

Development and validation of an LC-MS/MS method for the quantification of the KRAS^G12C inhibitor divarasib.